Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03830983
Other study ID # 18055313
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 8, 2019
Est. completion date January 31, 2023

Study information

Verified date March 2023
Source University Hospital Bispebjerg and Frederiksberg
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to evaluate left atrial structural and functional abnormalities in stroke of undetected mechanism and atherosclerotic stroke with cardiac MRI.


Description:

Aims and objectives: The goal of this study is to evaluate left atrial structural and functional abnormalities in patients with stroke of likely cardio-embolic origin compared with healthy age and sex matches controls and patients with atherosclerotic stroke using cardiac MRI. Background: Despite standard work up for the etiology of ischemic stroke, about 30% of the cases remain unexplained. It is increasingly accepted that these unexplained cases arise from disease outside of the brain. Paroxysmal AF (Atrial fibrillation) may often be suspected as the source but fewer than one third of patients with stroke of undetermined source manifest AF in any form even after 3 years of continuous heart rhythm monitoring. Emerging evidence suggest that atrial functional and structural abnormalities may convey a comparable risk of stroke in which AF is only one of several features. These abnormalities have been termed "atrial cardiomyopathy" and may be an efficient and practical approach to identify patients at high risk of AF and ischemic stroke. Methods and materials: Cross sectional and prospective cohort study with 3 different groups: 50 patients with stroke of undetected mechanism, 50 patients with atherosclerotic stroke (large or small vessel disease) admitted to the University Hospital of Bispebjerg and Frederiksberg and 50 sex and age matched controls with no history of stroke or AF from the Copenhagen City Heart Study (Ă˜BUS) will be included during a 2 year-period. The study will measure atrial structural abnormalities using cardiac magnetic resonance imaging (MRI) and atrial functional abnormalities by cardiac MRI and echocardiography. A 1 year follow up will examine the incidence of silent brain infarction with MRI and incidence of stroke, atrial fibrillation, acute myocardial infarction and cardiovascular death. Secondary endpoints are to examine the association of functional and structural changes found by MRI with echocardiography, rhythm abnormalities and biomarkers with the purpose of finding clinical easily applicable methods to diagnose atrial cardiomyopathy. Expected outcome and perspectives: The investigators hypothesize that patients with stroke of likely cardio-embolic origin have significantly more atrial fibrotic degeneration and reduced atrial emptying function than patients with atherosclerotic stroke and the control subjects. The investigators expect a higher incidence of silent brain infarction in the group with stroke of likely cardio-embolic origin. With atrial cardiomyopathy investigated thoroughly in patients with stroke of likely cardio-embolic origin the future work-up and treatment strategies could be more efficient and may thus improve the prognosis in terms of mortality and disability for a considerable number of patients.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date January 31, 2023
Est. primary completion date September 6, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria (Patients): 1. Stroke of likely cardioembolic cause or of undetected mechanism: Lesions in at least one territory on MRI & absence of significant large vessel disease defined as stenosis of cerebral or pre-cerebral vessels >50% in arteries supplying the ischemic area(s) & absence of severe small vessel disease including micro-bleeds on MRI. Patients with central retinal artery occlusion documented by perimeter and absence of significant large vessel disease defined as stenosis of cerebral or pre-cerebral vessels >50% & absence of severe small vessel disease including micro-bleeds on MRI are included independent of acute MRI findings. 2. Large or small vessel stroke (atherosclerotic stroke): Large vessel stroke: Acute lesions in one vascular territory on MRI, significant large vessel disease defined as stenosis of cerebral or pre-cerebral vessels >50% leading to the infarcted territory & absence of severe small vessel disease including micro-bleeds on MRI Small Vessel stroke: MRI documenting lacunar infarction, absence of significant large vessel disease defined as stenosis of cerebral or pre-cerebral vessels >50% and presence of severe small vessel disease possibly including micro bleeds. 3. Ischemic stroke within 30 days prior to inclusion 4. Age > 18 years 5. Life expectancy of at least one year 6. Informed consent - Stenosis: % defined by Ultrasound - Small vessel disease: defined according to STRIVE criteria Inclusion Criteria (Controls) 1. Age and sex matched healthy controls. Matched with the group with stroke of likely cardioembolic stroke. Exclusion Criteria (Patients): 1. Prior AF or AF >30 sec on at least 6 hours of monitoring during hospitalization. 2. Other major cardio-embolic risk sources assumed as cause of stroke (e.g. endocarditis, myocardial infarction within last 4 weeks, prosthetic cardiac valve) 3. Contraindications to MRI (Including eGFR<30 or other contraindications for the contrast agent used during Cardiac MRI) 4. Assumed unable to participate in the study by investigator (including but not restricted to psychiatric condition, dementia) Exclusion Criteria (Controls): 1. History of stroke or AF 2. Contraindications to MRI (Including eGFR<30 mL/min/1.73 m2 or other contraindications for the contrast agent used during Cardiac MRI) 3. Assumed unable to participate in the study by the investigator (For the same reasons listed above)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Denmark Bispebjerg Hospital Copenhagen NV Copenhagen

Sponsors (3)

Lead Sponsor Collaborator
University Hospital Bispebjerg and Frederiksberg Lundbeck Foundation, Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Observational study: Assessing incidence of stroke, acute myocardial infarction, atrial fibrillation and cardiovascular-death Follow up in patient records 1 year from last included patient
Primary Extent of the fibrosis in the Left Atrium (LA) Measured with gadolinium enhanced cardiac MRI Within 12 weeks from index event
Primary Left Atrial Emptying Function (LAEF) Measured with gadolinium enhanced cardiac MRI Within 12 weeks from index event
Secondary Observational study: Incidence of silent brain infarctions Incidence of silent brain infarctions assessed by follow-up MR-cerebrum (Only in patients) Between 1-2 years from index event
Secondary Left atrial volume Assessed by cardiac MRI Within 12 weeks from index event
Secondary Left atrial appendage morphology Assessed by cardiac MRI Within 8 weeks from index event
Secondary Left atrium volume 2D and 3D left atrial volume assessed by transthoracic echocardiography Within 12 weeks from index event
Secondary Left atrium ejection fraction (LAEF) Assessed by transthoracic echocardiography Within 12 weeks from index event
Secondary Speckle tracking of LA Assessed by transthoracic echocardiography Within 12 weeks from index event
Secondary Atrial rhythm abnormalities: Number of premature atrial contractions (PAC) per hour. Number and length of runs of PAC Assessed by 48-hours Holter monitoring Within 4 weeks from index event
Secondary Heart rate variability (HRV) Time domain variables (meanNN, SDNN, SDANN, SDNNidx, RMSSD, pNN50) Within 4 weeks from index event
Secondary Thrombophilia biomarkers Assessment of hypercoagulability Within 12 weeks from index event
Secondary Cardiac specific biomarkers Atrial Natriuretic Peptide, pro NT-Brain Natriuretic Peptide, High Sensitive Troponins. Within 12 weeks from index event
Secondary Inflammatory biomarkers High Sensitive CRP, Interleukins: IL1, IL1b, IL6, IL18 Within 12 weeks from index event
Secondary Fibrosis related markers Collagen type I and III Within 12 weeks from index event
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Suspended NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Enrolling by invitation NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Active, not recruiting NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis